1. PROSTAT-SPESİFİK MEMBRAN ANTİGEN MENENGİOM TEDAVİSİNDE YER ALABİLİR Mİ?
- Author
-
OĞUZOĞLU, Ali Serdar, ŞENOL, Nilgün, YASAN, Hasan, YÜCEER, Ramazan Oğuz, and ÇİRİŞ, İbrahim Metin
- Abstract
Objective In tumor development, tumor angiogenesis is an essential component, and a valuable marker in the differantial diagnosis of brain tumors. As menengiomas are highly vascular tumors in this study, we aimed to evaluate the expression of prostate-spesific membrane antigen (PSMA) in menengiomas by immunohistochemistry method to determine different target therapies. Material and Method Pathologic specimens with the diagnosis Grade I (n=32), Grade II (n=6) ve Grade III (n=10) of 48 patients operated for menengioma in our clinic, were evaluated for PSMA-antibody via immunohistochemical method. PSMA staining intensities in tumor tissue and tumor epithelium were analyzed. Vascular expression in tumoral and extratumoral stroma, and intensity score, according to PSMA expression, in tumoral epithelium were analyzed. Results Immunohistochemical analyses of different grade menengioma specimens showed no statistically significant differences between PSMA expression and PSMA staining intensities in tumor tissue and tumor epithelium (p>0.05). Conclusion Some molecular biomarkers, that take part in angiogenesis of agressive and unresectable menengiomas come into prominence. Although no significant results were achieved in terms of PSMA, as the molecular and genetic techniques progress, tumor biology manifestation and determination of potential targets will lead to new treatment procedures. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF